Drug intelligence / Profile preview

growth hormone + human pituitary follicle-stimulating hormone + GnRH antagonist

Development stage
Unknown
Modality
Recombinant Proteins and Enzymes, Peptides, Small Molecules
Administration
Subcutaneous
01

Overview

This is a combination therapy used in fertility treatments, particularly for assisted reproductive technologies like in vitro fertilization (IVF). The combination consists of three components with distinct functions: 1. **Growth hormone**: Enhances ovarian response to stimulation 2. **Human pituitary follicle-stimulating hormone (FSH)**: Stimulates the development of ovarian follicles 3. **GnRH antagonist**: Prevents premature ovulation by blocking gonadotropin-releasing hormone receptors This combination is typically used in controlled ovarian stimulation protocols for patients undergoing IVF, particularly those who may be poor responders to standard stimulation protocols.

02

Targets

FSHR (Follicle-stimulating hormone receptor)GnRHR (Gonadotropin-releasing hormone receptor)GHR (Growth hormone receptor)

Beyond the preview

Go deeper on growth hormone + human pituitary follicle-stimulating hormone + GnRH antagonist.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on growth hormone + human pituitary follicle-stimulating hormone + GnRH antagonist.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call